印度年轻起病2型糖尿病亚组揭示胰岛素缺乏为主要驱动因素
研究将欧洲衍生的五种亚组中心点应用于印度WellGen队列(n=1612)年轻起病2型糖尿病患者,并用k-means聚类验证。结果显示印度患者以严重胰岛素缺乏型(SIDD,53%)和轻度肥胖相关型(MOD,38%)为主,SIDD比例高于MOD,与欧洲队列相反;SIDD特征为胰岛素缺乏和高血糖,MOD为肥胖。
要点
- 印度年轻起病2型糖尿病以SIDD(53%)和MOD(38%)为主,SIDD更常见。
- SIDD特征为胰岛素缺乏和高血糖,MOD特征为肥胖。
- SIDD患者肾病和视网膜病变患病率高于MOD,MOD神经病变患病率更高。
核心结论
- 胰岛素缺乏是印度年轻2型糖尿病患者的主要驱动因素,而欧洲年轻患者以肥胖和胰岛素抵抗为主。
- 研究结果提示需重新审视印度年轻2型糖尿病的管理策略。
研究设计与样本
- 应用欧洲衍生的五种亚组中心点对WellGen队列(n=1612,诊断年龄<45岁)进行分型,并采用k-means聚类验证。
- 比较亚组间临床代谢特征和并发症率,并与欧洲ANDIS(n=962)和DIREVA(n=420)队列比较。
- 在另外两个印度队列Ahmedabad(n=187)和PHENOEINDY-2(n=205)中评估亚组分布。
主要发现
- WellGen队列中SIDD占53%,MOD占38%;而欧洲队列中SIDD和MOD比例分别为瑞典26% vs 68%、芬兰24% vs 71%。
- Ahmedabad队列SIDD占57%、MOD占33%;PHENOEINDY-2队列SIDD占67%、MOD占23%。
- 印度和欧洲队列中,SIDD均以胰岛素缺乏和高血糖为特征,MOD以肥胖为特征,SIRD以严重胰岛素抵抗为特征,MARD以轻度代谢内分泌紊乱为特征。
- WellGen队列中,SIDD患者肾病和视网膜病变患病率高于MOD,而MOD患者神经病变患病率更高。
临床怎么用
- 对印度年轻起病2型糖尿病患者,应评估胰岛素缺乏情况,考虑早期胰岛素治疗的可能性。
- 需关注SIDD亚组患者的肾病和视网膜病变筛查,以及MOD亚组患者的神经病变筛查。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIM/HYPOTHESIS: Five subgroups were described in European diabetes patients using a data driven machine learning approach on commonly measured variables. We aimed to test the applicability of this phenotyping in Indian individuals with young-onset type 2 diabetes. METHODS: We applied the European-derived centroids to Indian individuals with type 2 diabetes diagnosed before 45 years of age from the WellGen cohort (n = 1612). We also applied de novo k-means clustering to the WellGen cohort to validate the subgroups. We then compared clinical and metabolic-endocrine characteristics and the complication rates between the subgroups. We also compared characteristics of the WellGen subgroups with those of two young European cohorts, ANDIS (n = 962) and DIREVA (n = 420). Subgroups were also assessed in two other Indian cohorts, Ahmedabad (n = 187) and PHENOEINDY-2 (n = 205). RESULTS: Both Indian and European young-onset type 2 diabetes patients were predominantly classified into severe insulin-deficient (SIDD) and mild obesity-related (MOD) subgroups, while the severe insulin-resistant (SIRD) and mild age-related (MARD) subgroups were rare. In WellGen, SIDD (53%) was more common than MOD (38%), contrary to findings in Europeans (Swedish 26% vs 68%, Finnish 24% vs 71%, respectively). A higher proportion of SIDD compared with MOD was also seen in Ahmedabad (57% vs 33%) and in PHENOEINDY-2 (67% vs 23%). Both in Indians and Europeans, the SIDD subgroup was characterised by insulin deficiency and hyperglycaemia, MOD by obesity, SIRD by severe insulin resistance and MARD by mild metabolic-endocrine disturbances. In WellGen, nephropathy and retinopathy were more prevalent in SIDD compared with MOD while the latter had higher prevalence of neuropathy. CONCLUSIONS /INTERPRETATION: Our data identified insulin deficiency as the major driver of type 2 diabetes in young Indians, unlike in young European individuals in whom obesity and insulin resistance predominate. Our results provide useful clues to pathophysiological mechanisms and susceptibility to complications in type 2 diabetes in the young Indian population and suggest a need to review management strategies.
引用
- Prasad RB, Asplund O, Shukla SR, et al. Subgroups of patients with young-onset type 2 diabetes in India reveal insulin deficiency as a major driver. Diabetologia. 2021. PMID: 34689214. doi:10.1007/s00125-021-05543-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。